Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
08/04/2011 | US20110190214 Advantageous Salts of Mu-Opiate Receptor Peptides |
08/04/2011 | US20110190212 Cyclic tetrapeptides |
08/04/2011 | US20110190195 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
08/04/2011 | US20110190138 Methods and compositions for treating conditions |
08/04/2011 | US20110189651 Method and Device for Detecting Feline Immunodeficiency Virus |
08/03/2011 | EP2351833A1 Peptide-containing culture medium for culturing animal cell |
08/03/2011 | EP2350116A1 Treatment of biofilms |
08/03/2011 | EP2350115A1 Antimicrobial compounds |
08/03/2011 | EP2350114A1 Cyclic carboxamide compounds and analogues thereof as of hepatitis c virus |
08/03/2011 | CN102143970A Peptide analogs of alpha-melanocyte stimulating hormone |
08/02/2011 | US7989590 Peptides that increase collagen or hyaluronic acid production |
08/02/2011 | US7989587 SSX-2 peptides presented by HLA class II molecules |
08/02/2011 | US7988974 comprise a macromolecular carrier group fused to a gp41-derived DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LA1 gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells |
08/02/2011 | US7988957 Histone deacetylase inhibitor; adeno-associated virus vector; gene therapy; packages |
08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
08/02/2011 | CA2419285C New uses for amino acid anticonvulsants |
08/02/2011 | CA2321169C Modified enzymes and their use for peptide synthesis |
08/02/2011 | CA2162957C Cinnamic acid derivative |
08/02/2011 | CA2107569C Parathyroid hormone receptor and dna encoding same |
07/28/2011 | WO2011091357A1 Aromatic-cationic peptides and uses of same |
07/28/2011 | WO2011089396A2 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use. |
07/28/2011 | WO2011050342A3 Rational design of a biocompatible synthetic laminin-111 polymer and uses thereof |
07/28/2011 | US20110184147 Enzyme substrate for labeling of protein |
07/28/2011 | US20110183925 Anti-inflammatory peptide |
07/28/2011 | US20110183919 Novel dipeptidyl peptidase iv (dp-iv) compounds |
07/28/2011 | US20110183913 Novel lipid dipeptide and gel |
07/28/2011 | US20110183895 Polyheterocyclic compounds highly potent as hcv inhibitors |
07/28/2011 | US20110183891 Methods and Compositions for Inhibiting Fungal Infection and Disease |
07/28/2011 | US20110182864 Compositions containing inclusion complexes |
07/28/2011 | CA2787331A1 Aromatic-cationic peptides and uses of same |
07/28/2011 | CA2786690A1 Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use |
07/27/2011 | EP2348317A2 Analyzing nerve cell damage |
07/27/2011 | EP1912995B1 Macrocylic inhibitors of hepatitis c virus |
07/27/2011 | EP1432733B1 Method for identifying gene regulatory peptides |
07/27/2011 | CN102137849A Cyclic polyamines for binding phosphatidylserine |
07/27/2011 | CN101591348B Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof |
07/27/2011 | CN101401941B Preparation and uses of tumor-targeted carrier material RGD-fatty alcohol series of compounds |
07/26/2011 | US7985832 Antimicrobial cathelicidin peptides |
07/26/2011 | US7985771 Furanone derivatives |
07/26/2011 | CA2644467C Alpha crystalline form of perindopril arginine salt, its preparation process, and the pharmaceutical compositions that contain it |
07/26/2011 | CA2334315C Compounds with growth hormone releasing properties |
07/21/2011 | WO2011086553A1 Cyclic peptides, compositions comprising them and uses thereof as nucleases of nucleotidic macromolecules |
07/21/2011 | US20110178270 T-cell death-inducing epitopes |
07/21/2011 | US20110178069 Inhibitors of interleukin-1 beta converting enzyme |
07/21/2011 | US20110178027 Multi-LEU Peptides and Analogues Thereof as Selective PACE4 Inhibitors and Effective Antiproliferative Agents |
07/21/2011 | US20110177077 Pax 5 monoclonal antibody |
07/21/2011 | US20110177030 Hepatitis C Inhibitor Compounds |
07/20/2011 | EP2344518A1 Piperazine compounds with herbicidal effect |
07/20/2011 | EP2344516A1 Pseudoproline dipeptides |
07/20/2011 | EP1545613B1 Auristatin conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
07/20/2011 | CN1781933B Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |
07/20/2011 | CN102127144A Neotame-calcium chelate and preparation method thereof |
07/20/2011 | CN102127141A Esculentoside A, EsA as well as preparation method and application thereof |
07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
07/19/2011 | US7981998 Bis-sulfhydryl macrocyclization systems |
07/19/2011 | US7981997 Growth factor which acts through ErbB-4 RTK |
07/19/2011 | US7981862 Composition comprising BMP-2 amplifier/co-activator for enhancement of osteogenesis |
07/19/2011 | CA2448169C Peptides and the use thereof in darkening the skin |
07/14/2011 | WO2011083114A2 Serine hydrolase formulation |
07/14/2011 | US20110172155 Beta thymosin fragments |
07/14/2011 | US20110172145 Antimicrobial compounds |
07/14/2011 | US20110171690 Angiotensin converting enzyme inhibitory peptide |
07/14/2011 | US20110171175 Inhibitors of serine proteases |
07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
07/14/2011 | CA2804034A1 Prodrugs of heteraromatic compounds |
07/13/2011 | EP2343310A1 Serine hydrolase formulation |
07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
07/13/2011 | EP2343285A2 Peptoid compounds |
07/13/2011 | EP2343081A1 Interferon analogs |
07/13/2011 | EP1654283B1 Improved method of purifying tfpi and tfpi analogs |
07/13/2011 | CN102124346A Thrombin substrate and assay for determining the level of bioactive thrombin in a sample |
07/13/2011 | CN101044157B Compounds for proteasome enzyme inhibition |
07/12/2011 | US7977465 Peptidyl prodrugs and linkers and stabilizers useful therefor |
07/12/2011 | US7977119 Chemical arrays and methods of using the same |
07/12/2011 | CA2470078C Selective urokinase inhibitors |
07/07/2011 | WO2011081523A1 Interferon analogs |
07/07/2011 | WO2011081186A1 Flavor-enriching agent |
07/07/2011 | WO2011081185A1 Flavor-enriching agent |
07/07/2011 | WO2011081184A1 Lanthionine derivative |
07/07/2011 | WO2011080725A1 Compounds with both analgesic and anti-hyperalgesic efficacy |
07/07/2011 | US20110166073 Anti-hypertensive agent |
07/07/2011 | US20110166063 Polymer conjugates of therapeutic peptides |
07/07/2011 | US20110165647 Nanoparticle conjugates |
07/07/2011 | US20110165148 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
07/07/2011 | CA2786090A1 Interferon analogs |
07/07/2011 | CA2784310A1 Lanthionine derivatives |
07/07/2011 | CA2783415A1 Kokumi-imparting agent |
07/07/2011 | CA2783413A1 Kokumi-imparting agent |
07/06/2011 | EP2341066A1 Peptide having anti-diabetic activity and use thereof |
07/06/2011 | EP2341065A2 Inhibitors of serine proteases, particularly HCV NS3-NS4a protease |
07/06/2011 | EP2340830A2 Hepatitis C Virus Inhibitors |
07/06/2011 | EP2340822A1 Acylated 4-amidino and 4-guanidinobenzylamines for inhibiting plasma kallikreins |
07/06/2011 | EP2340725A1 Methods for the use of branched chain amino acids |
07/06/2011 | EP2340048A1 Polymer conjugates of biphalin peptides |
07/06/2011 | EP1228076B1 A substantially cell membrane impermeable compound and use thereof |
07/06/2011 | CN101429229B Method for producing high-purity glutathione |
07/05/2011 | US7973219 Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants |
07/05/2011 | US7973008 Metal-binding compounds and uses therefor |
07/05/2011 | US7972848 Isolation and identification of cross-reactive T cells |
07/05/2011 | US7972808 Digesting polypeptide mixture with proline-specific endoprotease and tripeptidase; recovering tripeptide products |